Vestal Point Capital »

Cytokinetics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $112M 2.1M 54.18

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Cytokinetics

BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Darwin Global Management
Bank of America Corporation
Armistice Capital
Geode Capital Management
T. Rowe Price Associates
Pentwater Capital Management
Boxer Capital
Vestal Point Capital
Alliancebernstein
Partner Fund Management
Marshall Wace

View all funds holding Cytokinetics